SCHEMBL3566604

SCHEMBL3566604

CN(C)Cc1ccc(NC=C2C(=O)NC(=O)c3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.41
PARP2 Q9UGN5 1/20 0.41
GSK3B P49841 1/20 0.39
PSD A5PKW4 2/20 0.38
ALDH1A1 P00352 7/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 2/20 0.37
TAAR1 Q96RJ0 1/20 0.36
MAPT P10636 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HTT P42858 2/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
CASP3 P42574 1/20 0.35
CASP2 P42575 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35
CASP8 Q14790 1/20 0.35
LSS P48449 1/20 0.34
TNKS O95271 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3566603 1.00 PARP1 (0.41) PARP1PARP2GSK3BPSDALDH1A1
SCHEMBL3564454 0.88 ACHE (0.40) PARP1PARP2GSK3BPSDALDH1A1
SCHEMBL3564457 0.88 ACHE (0.40) PARP1PARP2GSK3BPSDALDH1A1
SCHEMBL3565072 0.86 APP (0.41) ALDH1A1SMN1; SMN2TSHRTAAR1MAPT
SCHEMBL3565076 0.86 APP (0.41) ALDH1A1SMN1; SMN2TSHRTAAR1MAPT
SCHEMBL3573382 0.85 RORC (0.41) PARP1PARP2GSK3BPSDALDH1A1
SCHEMBL3573377 0.85 RORC (0.41) PARP1PARP2GSK3BPSDALDH1A1
SCHEMBL13343890 0.84 CDK4 (0.50) ALDH1A1MAPTNPSR1CASP3CDK4
SCHEMBL3573508 0.84 AKT1 (0.38) PARP1PARP2PSDSMN1; SMN2TSHR
SCHEMBL3573506 0.84 AKT1 (0.38) PARP1PARP2PSDSMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US claimed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 PARP1 1048/4885PARP2 1573/4885GSK3B 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.